Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000921895-23-000284
Filing Date
2023-02-06
Accepted
2023-02-06 09:00:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d12927018_02032023.htm SC 13D 267225
2 GROUP AGREEMENT ex991to13d12927018_02032023.htm EX-99.1 34226
  Complete submission text file 0000921895-23-000284.txt   303133
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Subject) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-39444 | Film No.: 23588774
SIC: 2834 Pharmaceutical Preparations

Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Filed by) CIK: 0001687509 (see all company filings)

EIN.: 300934659 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D